Immune globulin sulfonated human - Kaketsuken/Teijin

Drug Profile

Immune globulin sulfonated human - Kaketsuken/Teijin

Alternative Names: Freeze-dried sulfonated human immunoglobulin; GGS-CIDP; GGS-MMN; GGS-MPA; GGS-ON; IVIG - Kaketsuken/Teijin; Sulfonated human immunoglobulin; Venilon

Latest Information Update: 11 Jul 2016

Price : $50

At a glance

  • Originator Kaketsuken; Teijin
  • Class Immunoglobulins; Immunoproteins; Serum globulins
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Churg-Strauss syndrome; Infections
  • Phase III Chronic inflammatory demyelinating polyradiculoneuropathy; Microscopic polyangiitis; Motor neuron disease; Optic neuritis
  • Clinical Phase Unknown Idiopathic pulmonary fibrosis
  • Discontinued Multiple sclerosis

Most Recent Events

  • 31 Mar 2016 Freeze-dried sulfonated human immunoglobulin is still in phase III trials for Optic neuritis, Chronic inflammatory demyelinating polyradiculoneuropathy and Microscopic polyangiitis in Japan (IV) (Teijin Pharma pipeline, March 2016)
  • 30 Dec 2013 Phase-III clinical trials in Chronic inflammatory demyelinating polyradiculoneuropathy in Japan (IV) (JapicCTI142471)
  • 01 Dec 2013 Phase-III clinical trials in Microscopic polyangiitis in Japan (IV) (JapicCTI132394)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top